The genetics of lupus: a functional perspective, Arthritis Research & Therapy, vol.14, issue.3, p.211, 2012. ,
DOI : 10.1186/ar3844
Predictors of survival in systemic lupus erythematosus. Medicine (Baltimore), pp.147-56, 2006. ,
Combined Oral Contraceptives in Women with Systemic Lupus Erythematosus, New England Journal of Medicine, vol.353, issue.24, pp.2550-2558, 2005. ,
DOI : 10.1056/NEJMoa051135
Smoking, alcohol consumption, and risk of systemic lupus erythematosus in the Black Women's Health Study, J Rheumatol, vol.30, issue.6, pp.1222-1228, 2003. ,
Drug-Induced Lupus, Annals of the New York Academy of Sciences, vol.99, issue.1, 2007. ,
DOI : 10.1001/archinte.162.7.834
The cryptic interplay between systemic lupus erythematosus and infections, Autoimmunity Reviews, vol.13, issue.2, pp.96-102, 2014. ,
DOI : 10.1016/j.autrev.2013.09.004
Prevalence and incidence of systemic lupus erythematosus in France: A 2010 nation-wide population-based study, Autoimmunity Reviews, vol.13, issue.11, pp.1082-1091, 2014. ,
DOI : 10.1016/j.autrev.2014.08.034
Overall and Cause-Specific Mortality in Patients With Systemic Lupus Erythematosus: A Meta-Analysis of Observational Studies, Arthritis Care & Research, vol.327, issue.4, pp.608-624 ,
DOI : 10.1002/acr.22173
Osteoporosis and fractures in systemic lupus erythematosus, Arthritis Care & Research, vol.61, issue.Suppl, pp.2-8 ,
DOI : 10.1002/acr.20568
Loss of trabecular bone mineral density in systemic lupus erythematosus, Arthritis & Rheumatism, vol.35, issue.12, pp.1726-1760, 1993. ,
DOI : 10.1002/art.1780361212
Bone mineral density in postmenopausal Chinese patients with systemic lupus erythematosus, Lupus, vol.12, issue.2, pp.106-118, 2005. ,
DOI : 10.1191/0961203305lu2039oa
Bone mineral density changes in women with systemic lupus erythematosus, Clinical Rheumatology, vol.22, issue.4-5, pp.4-5318, 2003. ,
DOI : 10.1007/s10067-003-0743-0
Bone mineral density in premenopausal women with systemic lupus erythematosus, J Rheumatol, 2003. ,
Frequency of fractures in women with systemic lupus erythematosus: Comparison with united states population data, Arthritis & Rheumatism, vol.40, issue.5, pp.882-90, 1999. ,
DOI : 10.1002/1529-0131(199905)42:5<882::AID-ANR6>3.0.CO;2-C
Secondary osteoporosis in patients with an osteoporotic fracture, Best Practice & Research Clinical Rheumatology, vol.23, issue.6, pp.769-79, 2009. ,
DOI : 10.1016/j.berh.2009.09.006
Glucocorticoids, osteocytes, and skeletal fragility: The role of bone vascularity, Bone, vol.46, issue.3, pp.564-70, 2010. ,
DOI : 10.1016/j.bone.2009.06.030
Glucocorticoid-induced osteoporosis, Current Opinion in Endocrinology & Diabetes, vol.7, issue.6, pp.1319-1347, 2007. ,
DOI : 10.1097/00060793-200012000-00005
Use of Oral Corticosteroids and Risk of Fractures, Journal of Bone and Mineral Research, vol.44, issue.Suppl 45, pp.993-1000, 2000. ,
DOI : 10.1359/jbmr.2000.15.6.993
A Meta-Analysis of Prior Corticosteroid Use and Fracture Risk, Journal of Bone and Mineral Research, vol.359, issue.6, pp.893-902, 2004. ,
DOI : 10.1359/JBMR.040134
2014 update of recommendations on the prevention and treatment of glucocorticoid-induced osteoporosis, Joint Bone Spine, vol.81, issue.6 ,
DOI : 10.1016/j.jbspin.2014.10.001
Évolution de la prise encharge de l'ostéoporose cortisonique au sein du réseau rhumatisme inflam-matoire chronique du Nord-Pas-de-Calais entre, Rev, vol.77, 2007. ,
Osteoporosis screening, prevention, and treatment in systemic lupus erythematosus: application of the systemic lupus erythematosus quality indicators, Arthritis Care & Research, vol.40, issue.7, 2010. ,
DOI : 10.1002/acr.20150
Self-reported fractures and associated factors in women with systemic lupus erythematosus, J Rheumatol, vol.34, issue.10, pp.2018-2041, 2007. ,
Prevalence and predictors of fragility fractures in systemic lupus erythematosus, Annals of the Rheumatic Diseases, vol.64, issue.1, 2005. ,
DOI : 10.1136/ard.2003.018127
Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus, Arthritis & Rheumatism, vol.7, issue.7, pp.2044-50, 2005. ,
DOI : 10.1002/art.21110
Damage in systemic lupus erythematosus and its association with corticosteroids, Arthritis & Rheumatism, vol.13, issue.8, pp.1801-1809, 2000. ,
DOI : 10.1002/1529-0131(200008)43:8<1801::AID-ANR16>3.0.CO;2-O
Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992, Arthritis & Rheumatism, vol.71, issue.1, pp.46-50, 1999. ,
DOI : 10.1002/1529-0131(199901)42:1<46::AID-ANR6>3.0.CO;2-2
Morbidity and Mortality in Systemic Lupus Erythematosus During a 10-Year Period, Medicine, vol.82, issue.5, 2003. ,
DOI : 10.1097/01.md.0000091181.93122.55
Birmingham SLE cohort: outcomes of a large inception cohort followed for up to 21 years, Rheumatology, vol.54, issue.5, pp.836-879 ,
DOI : 10.1093/rheumatology/keu412
Mortality Associated With Systemic Lupus Erythematosus in France Assessed by Multiple-Cause-of-Death Analysis, Arthritis & Rheumatology, vol.64, issue.9, pp.2503-2514, 2014. ,
DOI : 10.1002/art.38731
Economic Implications of Hip Fracture: Health Service Use, Institutional Care and Cost in Canada, Osteoporosis International, vol.12, issue.4, pp.271-279, 2014. ,
DOI : 10.1007/s001980170116
Excess Mortality Following Vertebral Fracture, Journal of the American Geriatrics Society, vol.22, issue.Supplement 3, pp.338-347, 2000. ,
DOI : 10.1111/j.1532-5415.2000.tb02658.x
Bone mineral density in premenopausal women with systemic lupus erythematosus, J Rheumatol, vol.30, issue.11, pp.2365-2373, 2003. ,
Bone mineral density changes in women with systemic lupus erythematosus, Clinical Rheumatology, vol.22, issue.4-5, pp.4-5318, 2003. ,
DOI : 10.1007/s10067-003-0743-0
Frequency of and risk factors for symptomatic bone fractures in patients with systemic lupus erythematosus, Scandinavian Journal of Rheumatology, vol.46, issue.5, pp.390-393, 2013. ,
DOI : 10.1002/art.21110
Factors associated with low bone mineral density in female patients with systemic lupus erythematosus, J Rheumatol, vol.28, issue.1, pp.102-110, 2001. ,
Secondary osteoporosis in patients with an osteoporotic fracture, Best Practice & Research Clinical Rheumatology, vol.23, issue.6, pp.769-79, 2009. ,
DOI : 10.1016/j.berh.2009.09.006
Use of Oral Corticosteroids and Risk of Fractures, Journal of Bone and Mineral Research, vol.44, issue.Suppl 45, pp.993-1000, 2000. ,
DOI : 10.1359/jbmr.2000.15.6.993
Glucocorticoid-induced osteoporosis, Current Opinion in Endocrinology & Diabetes, vol.7, issue.6, pp.1319-1347, 2007. ,
DOI : 10.1097/00060793-200012000-00005
Glucocorticoid-Induced Osteoporosis and Osteonecrosis, Endocrinology and Metabolism Clinics of North America, vol.41, issue.3, pp.595-611, 2012. ,
DOI : 10.1016/j.ecl.2012.04.004
Évolution de la prise encharge de l'ostéoporose cortisonique au sein du réseau rhumatisme inflam-matoire chronique du Nord-Pas-de-Calais entre, Rev, vol.77, p.86, 2007. ,
Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus, Arthritis & Rheumatism, vol.7, issue.7, pp.2044-50, 2005. ,
DOI : 10.1002/art.21110
Prevalence and predictors of fragility fractures in systemic lupus erythematosus, Annals of the Rheumatic Diseases, vol.64, issue.1, 2005. ,
DOI : 10.1136/ard.2003.018127
Effects of maternal bisphosphonate use on fetal and neonatal outcomes, American Journal of Health-System Pharmacy, vol.71, issue.23, pp.2029-2065, 2014. ,
DOI : 10.2146/ajhp140041
Does Treatment With Bisphosphonates Endanger the Human Pregnancy?, Journal of Obstetrics and Gynaecology Canada, vol.30, issue.12, pp.1146-1154, 2008. ,
DOI : 10.1016/S1701-2163(16)34026-9
The 1982 revised criteria for the classification of systemic lupus erythematosus, Arthritis & Rheumatism, vol.31, issue.11, pp.1271-1278, 1982. ,
DOI : 10.1002/art.1780251101
Derivation of the sledai. A disease activity index for lupus patients, Arthritis & Rheumatism, vol.19, issue.6, pp.630-670, 1992. ,
DOI : 10.1002/art.1780350606
The development and initial validation of the systemic lupus international collaborating clinics/American college of rheumatology damage index for systemic lupus erythematosus, Arthritis & Rheumatism, vol.36, issue.3, pp.363-372, 1996. ,
DOI : 10.1002/art.1780390303
2014 update of recommendations on the prevention and treatment of glucocorticoid-induced osteoporosis, Joint Bone Spine, vol.81, issue.6, pp.493-501, 2014. ,
DOI : 10.1016/j.jbspin.2014.10.001
Osteoporosis screening, prevention, and treatment in systemic lupus erythematosus: application of the systemic lupus erythematosus quality indicators, Arthritis Care & Research, vol.40, issue.7, 2010. ,
DOI : 10.1002/acr.20150
Prevalence and risk factors of osteoporosis in female SLE patients-extended report. Rheumatol Oxf Engl, pp.1185-90, 2007. ,
Long-term complications of systemic lupus erythematosus, Rheumatology, vol.41, issue.10, pp.1095-100, 2002. ,
DOI : 10.1093/rheumatology/41.10.1095
Management of women with systemic lupus erythematosus, Maturitas, vol.75, issue.3, pp.207-221, 2013. ,
DOI : 10.1016/j.maturitas.2013.03.019
Screening and Treatment of Glucocorticoid-Induced Osteoporosis in Rheumatoid Arthritis Patients in an Urban Multispecialty Practice, JCR: Journal of Clinical Rheumatology, vol.15, issue.2, pp.61-65, 2009. ,
DOI : 10.1097/RHU.0b013e31819b65bd
Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: Rates and predictors of care in an academic rheumatology practice, Arthritis & Rheumatism, vol.280, issue.12, pp.3136-3178, 2002. ,
DOI : 10.1002/art.10613
Calcium Supplements Increase Risk of Myocardial Infarction, Journal of Bone and Mineral Research, vol.77, issue.2, p.2015 ,
DOI : 10.1002/jbmr.2311
Calcium supplements: benefits and risks, Journal of Internal Medicine, vol.89, issue.4, 2015. ,
DOI : 10.1111/joim.12394
Cardiovascular Complications of Calcium Supplements, Journal of Cellular Biochemistry, vol.66, issue.4, pp.494-501 ,
DOI : 10.1002/jcb.25028
Associations of dietary calcium intake and calcium supplementation with myocardial infarction and stroke risk and overall cardiovascular mortality in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition study (EPIC-Heidelberg) Heart Br Card Soc, pp.920-925, 2012. ,
Provider characteristics: impact on bone density utilization at a health maintenance organization, Menopause, vol.7, issue.6, pp.391-395, 2000. ,
DOI : 10.1097/00042192-200011000-00004
Adherence with osteoporosis practice guidelines: A multilevel analysis of patient, physician, and practice setting characteristics, The American Journal of Medicine, vol.117, issue.12, pp.919-943, 2004. ,
DOI : 10.1016/j.amjmed.2004.06.040
Use of bisphosphonates and dual-energy X-ray absorptiometry scans in the prevention and treatment of glucocorticoid-induced osteoporosis in rheumatology, QJM, vol.101, issue.4, pp.317-340, 2008. ,
DOI : 10.1093/qjmed/hcm126
High prevalence of vertebral deformity in premenopausal systemic lupus erythematosus patients, Lupus, vol.14, issue.7, pp.529-562, 2005. ,
DOI : 10.1191/0961203305lu2154oa
Homocysteine, bone mineral density, and fracture risk over 2 years of followup in women with and without systemic lupus erythematosus, J Rheumatol. Feb, vol.35, issue.2, pp.230-236, 2008. ,
Elevated risk of clinical fractures and associated risk factors in patients with systemic lupus erythematosus versus matched controls: a population-based study in the United Kingdom, Osteoporosis International, vol.57, issue.4, 2013. ,
DOI : 10.1007/s00198-013-2587-z
The Sandwell Project: A controlled evaluation of a programme of targeted screening for prevention of cardiovascular disease in primary care, BMC Public Health, vol.16, issue.1, p.73, 2008. ,
DOI : 10.1136/qshc.2006.019778
Patient and Other Factors Influencing the Prescribing of Cardiovascular Prevention Therapy in the General Practice Setting With and Without Nurse Assessment, Medical Decision Making, vol.32, issue.3, pp.498-506, 2012. ,
DOI : 10.1177/0272989X12437246
Increasing pneumococcal vaccination in managed care through telephone outreach, Am J Manag Care, vol.13, issue.10, pp.581-589, 2007. ,
Randomized controlled trial of a primary care-based screening program to identify older women with prevalent osteoporotic vertebral fractures: Cohort for skeletal health in Bristol and Avon (COSHIBA), Journal of Bone and Mineral Research, vol.23, issue.Suppl 1, pp.664-71, 2012. ,
DOI : 10.1002/jbmr.1478
Impact of a nurse-led programme on comorbidity management and impact of a patient selfassessment of disease activity on the management of rheumatoid arthritis: results of a prospective, multicentre, randomised, controlled trial (COMEDRA) Ann Rheum Dis, pp.2013-204733, 2014. ,
Reasons for non-vaccination in French rheumatoid arthritis and spondyloarthritis patients, Rheumatology, vol.54, issue.4, pp.748-50, 2015. ,
DOI : 10.1093/rheumatology/keu531